, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the

expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the offering of special

sugar supply surplus in 2018 which still affects current price, now trade around 12 - 13 cent/lb. As a result, the Company recorded a decrease in average sugar price from the previous year but the Company

sugar supply surplus in 2018 which still affects current price, now trade around 12 - 13 cent/lb. As a result, the Company recorded a decrease in average sugar price from the previous year. Therefore the

surplus in 2018 with the additional of domestic price decrease from the new sugar regime that domestic price will float along with global price. As a result, the Company recorded average sugar price

to 12,526 THB/ton. At the beginning of 2017, world sugar price has climbed up to 20 cent/lb then dropped sharply to 12 – 13 cent/lb now, due to global sugar supply is surplus in 2018 with the

previous year (2018 net profit was THB 272 million). The decrease was due to the following reasons: 1. Revenue from sugar was decrease due to Global supply surplus in 2019 with addition of domestic price

decrease was due to the following reasons: 1 Due to Global supply surplus in 2018 with addition of domestic price decrease from new sugar regime that domestic price will float. As a result, gross profit

quarter as well as a softer demand for biodiesel blending due to the impact from the coronavirus (COVID-19) . Thanks to the government policy to absorb crude palm oil surplus, the government delegated the

. Chapter1 General Provisions _____________________________ Division 1 Regulatory purpose _____________________________ Clause 2 Due to the undertaking of an intermediary as capital market servicer renders